Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Palliative dialysis: Addressing the need for alternative dialysis delivery modes.

Tentori F, Hunt A, Nissenson AR.

Semin Dial. 2019 Jun 2. doi: 10.1111/sdi.12820. [Epub ahead of print]

PMID:
31155777
2.

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, Winkelmayer WC, Ellenberg SS, Cifelli D, Madigan R, Young A, Angeletti M, Wingard RL, Kahn C, Nissenson AR, Maddux FW, Abbott KC, Landis JR.

J Am Soc Nephrol. 2019 May;30(5):890-903. doi: 10.1681/ASN.2018090945. Epub 2019 Apr 18.

PMID:
31000566
3.

Integrated Care in ESKD: Perspective of a Large Dialysis Organization.

Becker BN, Nissenson AR.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):445-447. doi: 10.2215/CJN.08300718. Epub 2019 Jan 29. No abstract available.

PMID:
30696663
4.

Greater access to transplantation should be a priority: A view of the Dialysis PATIENTS Demonstration Act.

Becker BN, Nissenson AR.

Am J Transplant. 2019 Apr;19(4):995-997. doi: 10.1111/ajt.15128. Epub 2018 Oct 29.

PMID:
30247816
5.

Hepatitis C virus infection in patients with end-stage renal disease.

Wigneswaran J, Van Wyck D, Pegues D, Gholam P, Nissenson AR.

Hemodial Int. 2018 Jul;22(3):297-307. doi: 10.1111/hdi.12672. Review.

PMID:
30141571
6.

Effects of Oral Nutritional Supplements on Mortality, Missed Dialysis Treatments, and Nutritional Markers in Hemodialysis Patients.

Benner D, Brunelli SM, Brosch B, Wheeler J, Nissenson AR.

J Ren Nutr. 2018 May;28(3):191-196. doi: 10.1053/j.jrn.2017.10.002. Epub 2017 Dec 6.

PMID:
29221626
7.

Collaboration key in winning NQF endorsement for medication management measure.

Nissenson AR, Jones ER.

Nephrol News Issues. 2017 May;31(5):12-13. No abstract available.

PMID:
30351583
8.

Nephrologists and Integrated Kidney Disease Care: Roles and Skills Essential for Nephrologists for Future Success.

Nissenson AR, Maddux FW.

Am J Kidney Dis. 2017 Jul;70(1):132-138. doi: 10.1053/j.ajkd.2017.02.372. Epub 2017 Apr 14.

PMID:
28416322
9.

Introduction to 30 Years: Lessons Learned in Dialysis.

Nissenson AR, Mehrotra R.

Semin Dial. 2017 Mar;30(2):85. doi: 10.1111/sdi.12578. Epub 2017 Feb 2. No abstract available.

PMID:
28155246
10.

Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, Nissenson AR, Jadoul M, Locatelli F, Winkelmayer WC, Port FK, Robinson BM, Tentori F.

Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17.

11.

Appropriate application of standardized care to improve ESRD patient outcomes.

Nissenson AR.

Nephrol News Issues. 2016 Nov;30(12):36-38. No abstract available.

PMID:
30645804
12.

Improving outcomes of dialysis patients by population health management-the Global Chief Medical Officer Initiative.

Canaud B, Hegbrant J, Nissenson AR, Barth C, Maddux F, Etter M, Krishnan M.

Lancet. 2016 Oct 22;388(10055):1966-1967. doi: 10.1016/S0140-6736(16)31894-3. No abstract available.

PMID:
27789006
13.

Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.

Kurella Tamura M, Chertow GM, Depner TA, Nissenson AR, Schiller B, Mehta RL, Liu S, Sirich TL; FHN Study.

J Am Soc Nephrol. 2016 Dec;27(12):3780-3787. Epub 2016 Jul 21.

14.

Strategies to improve access management.

Nissenson AR, Bradley D.

Nephrol News Issues. 2016 Mar;30(3):16-8. No abstract available.

PMID:
27169211
15.

A level playing field for patient access to transplant.

Nissenson AR.

Nephrol News Issues. 2016 Jan;30(1):28-9. No abstract available.

PMID:
26845796
16.

Medicare Advantage associated with lower mortality for incident dialysis patients.

Brunelli SM, Sibbel S, Colson C, Hunt A, Nissenson AR, Krishnan M.

Nephrol News Issues. 2015 Dec;29(13):16-7, 21, 26-9.

PMID:
26767249
17.

Delivering Better Quality of Care: Relentless Focus and Starting with the End in Mind at DaVita.

Nissenson AR.

Semin Dial. 2016 Mar-Apr;29(2):111-8. doi: 10.1111/sdi.12462. Epub 2016 Jan 8.

PMID:
26749498
18.

Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.

Rivara MB, Soohoo M, Streja E, Molnar MZ, Rhee CM, Cheung AK, Katz R, Arah OA, Nissenson AR, Himmelfarb J, Kalantar-Zadeh K, Mehrotra R.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):298-307. doi: 10.2215/CJN.06570615. Epub 2016 Jan 4.

19.

Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States.

Mehrotra R, Soohoo M, Rivara MB, Himmelfarb J, Cheung AK, Arah OA, Nissenson AR, Ravel V, Streja E, Kuttykrishnan S, Katz R, Molnar MZ, Kalantar-Zadeh K.

J Am Soc Nephrol. 2016 Jul;27(7):2123-34. doi: 10.1681/ASN.2015050472. Epub 2015 Dec 10.

20.

Prioritizing fluid management for the renal community.

Jones ER, Nissenson AR.

Nephrol News Issues. 2015 Jan;29(1):28-30. No abstract available.

PMID:
26470544
21.

Socioeconomic Status of Counties Where Dialysis Clinics Are Located Is an Important Factor in Comparing Dialysis Providers.

Almachraki F, Tuffli M, Lee P, Desmarais M, Shih HC, Nissenson AR, Krishnan M.

Popul Health Manag. 2016 Feb;19(1):70-6. doi: 10.1089/pop.2014.0158. Epub 2015 Jun 19.

PMID:
26090696
22.

ESRD special needs plans: a proof of concept for integrated care.

Krishnan M, Franco E, McMurray S, Petra E, Nissenson AR.

Nephrol News Issues. 2014 Nov;28(12):30, 32, 34-6.

PMID:
26012119
23.

Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.

Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, Nissenson AR, Kestenbaum B, de Boer IH, Himmelfarb J, Mehrotra R.

J Am Soc Nephrol. 2015 Jul;26(7):1671-81. doi: 10.1681/ASN.2014050472. Epub 2015 Jan 22.

24.

For-profit dialysis providers.

Nissenson AR.

Health Aff (Millwood). 2014 Nov;33(11):2082. doi: 10.1377/hlthaff.2014.1100. No abstract available.

PMID:
25368009
25.

The evolving role of the medical director of a dialysis facility.

Maddux FW, Nissenson AR.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):326-30. doi: 10.2215/CJN.04920514. Epub 2014 Oct 2.

26.

Developing a blueprint for quality.

Jones E, Nissenson AR.

Nephrol News Issues. 2014 Jun;28(7):8, 13. No abstract available.

PMID:
25055432
27.

Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation.

Brunelli SM, Wilson S, Krishnan M, Nissenson AR.

BMC Nephrol. 2014 Jul 21;15:121. doi: 10.1186/1471-2369-15-121.

28.

Elderly patients starting outpatient dialysis not at excessive mortality risk.

Brunelli SM, Nissenson AR, Krishnan M.

Hemodial Int. 2014 Jul;18(3):583-4. doi: 10.1111/hdi.12167. No abstract available.

PMID:
25039990
29.

Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients.

Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K.

Kidney Int Suppl (2011). 2013 Dec;3(5):462-468.

30.

New alternatives in anemia treatment: biosimilars and HIF stabilizers.

Krishnan M, Nissenson AR.

Nephrol News Issues. 2014 May;28(6):24-8. Review. No abstract available.

PMID:
24908823
31.

Dose of hemodialysis and survival: a marginal structural model analysis.

Lertdumrongluk P, Streja E, Rhee CM, Park J, Arah OA, Brunelli SM, Nissenson AR, Gillen D, Kalantar-Zadeh K.

Am J Nephrol. 2014;39(5):383-91. doi: 10.1159/000362285. Epub 2014 Apr 26.

32.

Guiding principles and checklist for population-based quality metrics.

Krishnan M, Brunelli SM, Maddux FW, Parker TF 3rd, Johnson D, Nissenson AR, Collins A, Lacson E Jr.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1124-31. doi: 10.2215/CJN.11061013. Epub 2014 Feb 20.

33.

Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities.

Rhee CM, Lertdumrongluk P, Streja E, Park J, Moradi H, Lau WL, Norris KC, Nissenson AR, Amin AN, Kovesdy CP, Kalantar-Zadeh K.

Am J Nephrol. 2014;39(3):183-94. doi: 10.1159/000358497. Epub 2014 Feb 15.

34.

Toward population management in an integrated care model.

Maddux FW, McMurray S, Nissenson AR.

Blood Purif. 2013;36(3-4):152-9. doi: 10.1159/000356095. Epub 2013 Dec 20. Review.

35.

Improving outcomes for ESRD patients: shifting the quality paradigm.

Nissenson AR.

Clin J Am Soc Nephrol. 2014 Feb;9(2):430-4. doi: 10.2215/CJN.05980613. Epub 2013 Nov 7.

36.

Effect of age and dialysis vintage on obesity paradox in long-term hemodialysis patients.

Vashistha T, Mehrotra R, Park J, Streja E, Dukkipati R, Nissenson AR, Ma JZ, Kovesdy CP, Kalantar-Zadeh K.

Am J Kidney Dis. 2014 Apr;63(4):612-22. doi: 10.1053/j.ajkd.2013.07.021. Epub 2013 Oct 9.

37.

Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients.

Park J, Mehrotra R, Rhee CM, Molnar MZ, Lukowsky LR, Patel SS, Nissenson AR, Kopple JD, Kovesdy CP, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2013 Aug;28(8):2146-55. doi: 10.1093/ndt/gft213. Epub 2013 Jun 5.

38.

Nutritional predictors of early mortality in incident hemodialysis patients.

Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K.

Int Urol Nephrol. 2014 Jan;46(1):129-40. doi: 10.1007/s11255-013-0459-2. Epub 2013 May 24.

39.

Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients.

Lertdumrongluk P, Rhee CM, Park J, Lau WL, Moradi H, Jing J, Molnar MZ, Brunelli SM, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K.

J Ren Nutr. 2013 Nov;23(6):411-21. doi: 10.1053/j.jrn.2013.01.018. Epub 2013 Apr 28.

40.

A quality initiative. Reducing rates of hospitalizations by objectively monitoring volume removal.

Parker TF 3rd, Hakim R, Nissenson AR, Krishnan M, Bond TC, Chan K, Maddux FW, Glassock R.

Nephrol News Issues. 2013 Mar;27(3):30-2, 34-6.

PMID:
23581174
41.

Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients.

Park J, Jin DC, Molnar MZ, Dukkipati R, Kim YL, Jing J, Levin NW, Nissenson AR, Lee JS, Kalantar-Zadeh K.

Mayo Clin Proc. 2013 May;88(5):479-86. doi: 10.1016/j.mayocp.2013.01.025. Epub 2013 Apr 4.

42.

Toward population management in an integrated care model.

Maddux FW, McMurray S, Nissenson AR.

Clin J Am Soc Nephrol. 2013 Apr;8(4):694-700. doi: 10.2215/CJN.09050912. Epub 2013 Mar 28.

43.

Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis.

Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K.

Clin J Am Soc Nephrol. 2013 Apr;8(4):619-28. doi: 10.2215/CJN.04810512. Epub 2013 Jan 10.

44.

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.

Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P.

Am J Kidney Dis. 2013 Feb;61(2):238-46. doi: 10.1053/j.ajkd.2012.08.043. Epub 2012 Nov 16.

PMID:
23159232
45.

Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.

Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, Mehta RL, Kliger AS, Stokes JB; Frequent Hemodialysis Network (FHN) Trial Group.

Am J Kidney Dis. 2013 Feb;61(2):228-37. doi: 10.1053/j.ajkd.2012.09.009. Epub 2012 Nov 11.

46.

The normal HCT trial re-revisited: what were the actual findings?

Besarab A, Bolton WK, Nissenson AR, Schwab SJ.

Kidney Int. 2012 Jul;82(2):242; author reply 242-3. doi: 10.1038/ki.2012.204. No abstract available.

47.

CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end-stage renal disease.

Wilson SM, Mayne TJ, Krishnan M, Holland J, Volz A, Good LS, Nissenson AR.

Hemodial Int. 2013 Jan;17(1):86-93. doi: 10.1111/j.1542-4758.2012.00721.x. Epub 2012 Jun 29.

PMID:
22742528
48.

Patterns and predictors of early mortality in incident hemodialysis patients: new insights.

Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K.

Am J Nephrol. 2012;35(6):548-58. doi: 10.1159/000338673. Epub 2012 Jun 6.

49.

The IMPACT (Incident Management of Patients, Actions Centered on Treatment) program: a quality improvement approach for caring for patients initiating long-term hemodialysis.

Wilson SM, Robertson JA, Chen G, Goel P, Benner DA, Krishnan M, Mayne TJ, Nissenson AR.

Am J Kidney Dis. 2012 Sep;60(3):435-43. doi: 10.1053/j.ajkd.2012.04.009. Epub 2012 May 17.

PMID:
22607688
50.

Response to "Disparities in provision of transplant information affect access to kidney transplantation" by Kucirka et al.

Nissenson AR, Krishnan M.

Am J Transplant. 2012 Aug;12(8):2255-6; author reply 2257. doi: 10.1111/j.1600-6143.2012.04106.x. Epub 2012 May 17. No abstract available.

Supplemental Content

Loading ...
Support Center